Sam Brusco, Associate Editor05.18.22
XACT Robotics, developer of a robotic system for interventional radiology, has received U.S. Food and Drug Administration (FDA) clearance for a modification to its already cleared XACT ACE robotic system for robotic ablation probe insertion and steering during ablation procedures.
The additional clearance expands the company’s indication for CT-guided percutaneous procedures.
“Ablation procedures are challenging to many users in terms of the accuracy and time required to place the ablation probes” Harel Gadot, founder and executive chairman of XACT Robotics told the press. “The proven ability of our system to reach relatively small targets, regardless of target movement or obstacles, with unparalleled accuracy and one insertion to target will provide better patient outcomes with greater efficiencies. Moreover, with the addition of the newly cleared ablation capabilities, we can now provide even more value to our partners by increasing the utilization of our system."
XACT ACE combines image-based procedure planning and real-time monitoring with hands-free robotic insertion and non-linear steering. Fast and accurate ablation probe placement helps save time, contributing to overall efficiency and success.
XACT ACE’s instruments are delivered to a desired target in the body via robotic insertion and non-linear steering, overcoming size, depth, movement, or obstructions. According to the company, the system has achieved 1.7mm tip to target average accuracy on first insertion, with under 8.5 minutes average skin to target time.
The additional clearance expands the company’s indication for CT-guided percutaneous procedures.
“Ablation procedures are challenging to many users in terms of the accuracy and time required to place the ablation probes” Harel Gadot, founder and executive chairman of XACT Robotics told the press. “The proven ability of our system to reach relatively small targets, regardless of target movement or obstacles, with unparalleled accuracy and one insertion to target will provide better patient outcomes with greater efficiencies. Moreover, with the addition of the newly cleared ablation capabilities, we can now provide even more value to our partners by increasing the utilization of our system."
XACT ACE combines image-based procedure planning and real-time monitoring with hands-free robotic insertion and non-linear steering. Fast and accurate ablation probe placement helps save time, contributing to overall efficiency and success.
XACT ACE’s instruments are delivered to a desired target in the body via robotic insertion and non-linear steering, overcoming size, depth, movement, or obstructions. According to the company, the system has achieved 1.7mm tip to target average accuracy on first insertion, with under 8.5 minutes average skin to target time.